(Total Views: 650)
Posted On: 06/02/2023 12:00:50 PM
Post# of 149014
Takeda gives up on liver therapy partnership. The full article is behind a paywall, this is the snippet that they let us read.
https://endpts.com/takeda-ends-2021-deal-with...%20rethink
Quote:
Less than two years after Takeda inked a collaboration with Poseida Therapeutics to develop six liver-directed and hematopoietic stem cell-directed in vivo gene therapies, Takeda will end the partnership on July 30, the company confirmed to Endpoints News.
The breakup is not unexpected, coming on the heels of Takeda’s April announcement that it planned to stop discovery and preclinical work in AAV gene therapy, as well as research and preclinical work on rare hematology. A representative for Takeda confirmed that the partnership ended because of the company’s decision to stop that work.
https://endpts.com/takeda-ends-2021-deal-with...%20rethink
(2)
(0)Scroll down for more posts ▼
